l-carnitine half life Pharmacokinetics of | Clinical Pharmacokinetics half life of l carnitine
Description
L- , ,
Understanding the specific mechanisms of TMAO in the progression and pathogenesis of CVDs will facilitate the development of new therapeutic approaches, and holds great promise for precise intervention in the occurrence of CVDs (32)
10.1016/j.cmet.2012.12.011 8 BruntV
F.HolochP
10.1023/A:1024433100257
Contras: Puede no ser adecuado para personas que prefieren comprimidos en lugar de cpsulas
